Drugs used in the treatment of type 2 diabetes Flashcards
How often should a type 2 diabetic be seen for review? What should the review include?
Review of symptoms
▪ Review clinical issues – glucose levels, BP, cholesterol, urine
albumin creatinine ratio (ACR)
▪ Screen for complications – Eyes - digital retinal photography yearly
Feet - yearly check for nerves and pulses
Kidneys - yearly ACR and estimated GFR (ie serum creatinine)
▪ Issues identified can be addressed at subsequent visits
▪ An opportunity to develop targets over the next year
What is the goal blood pressure for diabetic patients?
What is the first line medication recommended to control hypertension in diabetics?
140/80 mmHg (130/80 mmHg if CVD or Renal d) (some places = 135/85)
First line Ace inhibitors
then
calcium Channel blockers
often need > 2 medications
When should a diabetic patient be put on a statin?
What is the aim for total cholesterol and LDL?
Diabetic >40 or Diabetic <40 + 1 risk factor
total cholesterol aim = <4.0 mmol
LDL = <2.0 mmol
What is the goal cholesterol level for diabetic patients?
Aim for total cholesterol < 4.0 mmol/L, LDL < 2.0 mmol/L
Which blood test is used to replace HbA1c if it becomes invalid for some reason e.g haemoglobinopathies?
Fructosamine
lasts around 2 weeks
May be useful in to measure glucose control in pregnancy
What type of carbohydrates are recommended for diabetic patients?
low glycaemic index
How much exercise is recommended for diabetic patients?
at least 30 minutes vigorous exercise 3x per week
Name all 7 drugs used to treat diebetes?
Sulfonylureas / Prandial glucose regulators (PGRs)
Biguanides
Alpha glucosidase inhibitors
Thiazolidinediones (glitazones)
DPP-4 inhibitors
GLP-1 analogues
Insulin
Name the Biguanide drug is used to treat diabetes. State its mode of action, positive components and potential side effects
Metformin
MOA - Enhances the effect of insulin - increases insulin sensitivity.
Reduce the rate of gluconeogenesis, and hence hepatic glucose output
Positives -
- Does not cause hypoglycaemia
- Does not cause weight gain
- Suitable for those over weight
S.E -
- Lactic acidosis (avoid in people with sever hepatic or renal disease)
- Stop using when serum creatinine >150 µmol/L.
- Weight loss
- GI disturbances (diarrhoea, abdominal cramps)
- Reduces vitamin B 12 absorption
Describe the relationship between the use of metformin and the administration of iodinated contrast agent?
Metformin must be stopped prior to intravascular administration of iodinated contrast agent because of the risk of renal failure and subsequent lactic acidosis. Restart no earlier than 48 h after test of renal function has shown no deterioration.
Name the Sulphonylureas drugs used to treat diabetes. State their mode of action, positive components and potential side effects
Drugs - Gliclazide, glyburine, glimperide, Chlorpropamide, Glibenclamide, Tolbutamide
MOA
- Increases insulin secretion from Beta cells. Bind to the sulphonylurea receptor on the cell membrane, which closes ATP-sensitive potassium channels and blocks potassium efflux. The resulting depolarization promotes influx of calcium, a signal for insulin release
Positives -
- Cheap
- Effective in obtaining short term (1-3y) glucose control
S.E
- ineffective in patients with no functional β-cell mass
- Avoid in pregnancy
- Increased cardiovascular morbidity and mortality
- Weight gain (do not use if over weight)
- Hypoglycaemia
- should be used with care in patients with liver disease
- Patients with renal impairment should use sulphonylureas primarily excreted by the liver
Which Sulphonylureas drugs can be used in renal impairment?
Gliclazide
Tolbutamide
Name the Meglitinides drugs used to treat diabetes. State their mode of action and potential side effects
Drugs -
Repaglinide and Nateglinide
MOA- Increases insulin secretion from Beta cells in response to meals.
S.E
- Hypoglycaemia
- Weight gain
- Do not use in sever renal or liver failure
Name the Thiazolidinediones drug used to treat diabetes. State their mode of action and potential side effects
Drugs
- Pioglitazone
MOA-
- Reduce insulin resistance by stimulating peroxisome proliferator-activated receptor-gamma (PPAR-γ)
- Increase transcription of adipokines
- hepatic glucose production
- enhance peripheral glucose uptake
S.E
- weight gain of 5–6 kg
- Fluid retention (oedema)
- heart failure and a modestly increased risk of bladder cancer
- Mild anaemia
- Osteoporosis (increased risk of bone fractures)
Should not be used in patients with
- Congestive heart failure
- Liver failure
Where are peroxisome proliferator-activated receptor-gamma (PPAR-γ) receptors mainly found?
Fat cells
Name the Dipeptidyl peptidase-4 inhibitors (DPP-4 inhibitors) drugs used to treat diabetes. State their mode of action, positive components and potential side effects
Drug -
Saxagliptin
Sitagliptin
alogliptin
MOA-
- Normally DPP-4 inactivates glucagon-like peptide-1 (GLP-1)
- Th drug Inhibits GLP-1 degradation
- increase glucose dependant insulin secretion
- lowers glucagon secretions
- most effective in the early stages of type 2 diabetes, when insulin secretion is relatively preserved
Positives -
- moderate effect in lowering blood glucose
- weight-neutral
S.E
- nausea
- acute pancreatitis
- Athralgia
- Headaches
- Dizziness
- Nasopharyngitis
Do not use in liver failure or moderate to sever renal failure
Name the Sodium/glucose transporter 2 inhibitors (SGLT2 inhibitor) drugs used to treat diabetes. State their mode of action, positive components and potential side effects
Drugs
- Canagliflozin
- Dapagliflozin
- Empagliflozin
MOA-
(SGLT2) is a sodium-dependent glucose transport protein located in the proximal renal tubules, whose function is to reabsorb glucose from the renal filtrate and restore it to the circulation.
- Increases excretion of glucose in the urine
Positives
- Causes weight loss
- Small reductions in systolic blood pressure
S.E
- increase in genital candidiasis
- small increase in urinary tract infections
- Polyuria
- Dehydration
- a decrease in cardiovascular mortality
- Diabetic ketoacidosis
Name the GLP-1 agonists drugs used to treat diabetes. State their mode of action, positive components and potential side effects
Drug
- Exenatide
- Lixisenatide
- Liraglutide
- Albiglutide
Injectable drugs
MOA-
- Directly stimulate GLP-1 receptor
- increase insulin secretion
- inhibit glucagon secretion
- delay gastric emptying
- have central effects on appetite
Positives
- Weight loss
- Decreases food intake and induces satiety
S.E
- limited benefit in 30% of those treated
- nausea
- acute pancreatitis
- Pancreatic cancer
- acute kidney injury
used as an alternative to insulin, particularly in the overweight
Do not use in those with pre-existing gut motility disorders
only allowed to be given to people with BMI >35 kg/m2 and poor glucose control
Name the alpha glucosidase inhibitor drugs used to treat diabetes. State their mode of action, positive components and potential side effects
Drug
- Acarbose
MOA-
Reduce intestinal glucose absorption
S.E GI complaints (fluctuance, diarrhoea, feeling full)
Do not use in those with pre-existing intestinal issues e.g. IBD, )
Do not use in sever renal failure
Where does GLP-1 come from and which cell produces it?
L-cells in the GI-tract
What is the guideline for the treatment of type 2 diabetes with glucose lower drugs
HbA1c >48 mmol/mol after lifestyle Metformin Consider sulfonylurea if not overweight, metformin contraindicated, not tolerated
HbA1c >48 mmol/mol \+ sulfonylurea Consider PGRs if erratic lifestyle pioglitazone or DPP-4 here if hypoglycaemia a problem, or metformin not tolerated
HbA1c >58 mmol/mol
+ pioglitazone or gliptin (DPP-4 inhibitors) or insulin
Consider GLP-1 analogue if: BMI >35,
HbA1c >58 mmol/mol
insulin + metformin + sulphonylurea
HbA1c >58 mmol/mol
Intensify insulin or add glitazone
Consider pioglitazone + insulin if high dose insulin
ineffective
How should metformin be taken?
Slow titration of metformin, take after meals
Before a patient is put on metformin and while they are on metformin their eGFR should be assessed, why?
Care with dose of metformin of eGFR <45, stop if <30.
What are the indications for starting insulin therapy in type 2 diabetics?
inadequate glycaemic control on tablets
contraindications to tablets
symptomatic hyperglycaemia
pregnancy
infection / foot ulcers
How is insulin given in those with types 2 diabetes?
Once-daily - intermediate or long acting insulin, given in addition to tablets. Usually given before bed or first thing in the morning
Twice-daily - premixed insulin twice daily
morning and evening. Contains basal and short acting component
Basal bolus therapy - 3 injections of rapid acting, 1 injection of long acting
Mimics normal physiology
Breakfast, lunch, dinner, long acting at night before bed
intermediate- or
long-acting (basal) insulin